from the United States Court of Appeals for the Federal Circuit
See other cases from the Federal Circuit.
Reply of petitioners Hikma Pharmaceuticals USA Inc. et al. filed. (Distributed)
CIRCULATED
Brief amicus curiae of Sanofi filed. (Distributed)
Brief amici curiae of Pharmaceutical Research and Manufacturers of America, et al. filed. (Distributed)
Brief amici curiae of Academic Medical Centers filed. (Distributed)
Brief amicus curiae of Regeneron Pharmaceuticals, Inc. filed. (Distributed)
Brief amici curiae of Former Federal Circuit Chief Judge Paul R. Michel, et al. filed. (Distributed)
Brief amici curiae of AbbVie Inc., et al. filed. (Resubmitted) (Distributed)
Amicus brief of AbbVie Inc. not accepted for filing. (To be resubmitted - March 27, 2026)
Brief amicus curiae of American Intellectual Property Law Association filed. (Distributed)
Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument GRANTED.
Brief of respondents Amarin Pharma, Inc., et al. filed.
Brief amici curiae of Patent Law Professors Paul R. Gugliuzza and Jacob S. Sherkow in support of neither party filed.
Brief amicus curiae of Licensing Executives Society (USA and Canada), Inc. in support of neither party filed.
Brief amicus curiae of Intellectual Property Owners Association in support of neither party filed.
Brief amicus curiae of The Public Interest Patent Law Institute in support of neither party filed.
Brief amicus curiae of New York Intellectual Property Law Association filed.
Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument filed.
Brief amicus curiae of United States filed.
Brief amicus curiae of Former Congressman Henry A. Waxman filed.
Brief amicus curiae of Association for Accessible Medicines filed.
Brief amicus curiae of Public Citizen filed.
Sealed material received electronically from the United States District Court for the District of Delaware and available with the Clerk. The remainder of the record is electronic and is available on PACER.
Brief amicus curiae of Shashank Upadhye filed.
Record received from the United States Court of Appeals for the Federal Circuit. The record is electronic and is available on PACER.
Record requested from the United States Court of Appeals for the Federal Circuit.
Brief amici curiae of 76 Scholars filed.
Joint appendix filed. (Statement of costs filed)
Brief of petitioners Hikma Pharmaceuticals USA Inc., et al. filed.
SET FOR ARGUMENT on Wednesday, April 29, 2026.
Petition GRANTED.
Supplemental brief of respondents Amarin Pharma, Inc., et al. filed. (Distributed)
Letter of Hikma Pharmaceuticals USA Inc. and Hikma Pharmaceuticals PLC filed.
Brief amicus curiae of United States filed.
The Solicitor General is invited to file a brief in this case expressing the views of the United States.
Reply of petitioners Hikma Pharmaceuticals USA Inc., et al. filed. (Distributed)
Brief of respondents Amarin Pharma, Inc., et al. in opposition filed.
Motion to extend the time to file a response is granted and the time is further extended to and including May 15, 2025.
Motion to extend the time to file a response from April 21, 2025 to May 15, 2025, submitted to The Clerk.
Brief amicus curiae of Association for Accessible Medicines filed.
Brief amici curiae of 30 Scholars of Law, Economics, and Medicine filed.
Motion to extend the time to file a response is granted and the time is extended to and including April 21, 2025.
Motion to extend the time to file a response from March 21, 2025 to April 21, 2025, submitted to The Clerk.
Petition for a writ of certiorari filed. (Response due March 21, 2025)
Application (24A652) granted by The Chief Justice extending the time to file until February 14, 2025.
Application (24A652) to extend the time to file a petition for a writ of certiorari from January 15, 2025 to February 14, 2025, submitted to The Chief Justice.
Hikma Pharmaceuticals USA Inc. and Hikma Pharmaceuticals PLC, Petitioner, represented by Charles Bennett Klein
Amarin Pharma, Inc., et al., Respondent, represented by Michael Robert Huston
30 Scholars of Law, Economics, and Medicine, Amicus Curiae, represented by Charles Duan
76 Scholars of Law, Business, Economics, and Medicine, Amicus Curiae, represented by Charles Duan
Abbvie Inc., Amicus Curiae, represented by Jonathan S. Massey
AbbVie Inc. and Bristol-Myers Squibb Company, Amicus Curiae, represented by Jonathan S. Massey
American Intellectual Property Law Association, Amicus Curiae, represented by Barbara A. Fiacco
Association for Accessible Medicines, Amicus Curiae, represented by Matthew S. Hellman
Association for Accessible Medicines, Amicus Curiae, represented by William McGinley Jay
Former Congressman Henry A. Waxman, Amicus Curiae, represented by William Barnett Schultz
Former Federal Circuit Chief Judge Paul R. Michel and Scholars of Law and Economics, Amicus Curiae, represented by Gregory Andrew Castanias
Intellectual Property Owners Association, Amicus Curiae, represented by Paul H. Berghoff
Licensing Executives Society (USA and Canada), Inc., Amicus Curiae, represented by Brian Patrick O'Shaughnessy
New York Intellectual Property Law Association, Amicus Curiae, represented by Paul Anthony Coletti
Patent Law Professors Paul R. Gugliuzza and Jacob S. Sherkow, Amicus Curiae, represented by Phillip Robert Malone
Patent Law Professors Paul R. Gugliuzza and Jacob S. Sherkow, Amicus Curiae, represented by Nina Kosana Srejovic
Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization, Amicus Curiae, represented by Sarah Elaine Harrington
Public Citizen, Amicus Curiae, represented by Scott Lawrence Nelson
Regeneron Pharmaceuticals, Inc., Amicus Curiae, represented by Farheena Yasmeen Rasheed
Sanofi, Amicus Curiae, represented by Zachary D. Tripp
Shashank Upadhye, Amicus Curiae, represented by Shashank S. Upadhye
The Academic Medical Centers, Amicus Curiae, represented by Ronald Edmund Cahill
The Public Interest Patent Law Institute, Amicus Curiae, represented by Christopher Theodore Bavitz
United States of America, Amicus Curiae, represented by D. John Sauer